Home - Products - Angiogenesis - CDK - BML-259

BML-259

CAS No. 267654-00-2

BML-259( CAY10554 )

Catalog No. M28107 CAS No. 267654-00-2

BML-259 is an inhibitor of CDK5 and CDK2 with IC50s of 64 and 98 nM, respectively. BML-259 can be used in studies about the treatment of cancer and neurodegenerative diseases.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	39	Get Quote
10MG	69	Get Quote
25MG	155	Get Quote
50MG	264	Get Quote
100MG	462	Get Quote
500MG	981	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

BML-259
Note

Research use only, not for human use.
Brief Description

BML-259 is an inhibitor of CDK5 and CDK2 with IC50s of 64 and 98 nM, respectively. BML-259 can be used in studies about the treatment of cancer and neurodegenerative diseases.
Description

BML-259 is an inhibitor of CDK5 and CDK2 with IC50s of 64 and 98 nM, respectively. BML-259 can be used in studies about the treatment of cancer and neurodegenerative diseases.(In Vitro):BML-259 prevents a large population of cells from NAC-evoked cell death.
In Vitro

BML-259 (10 μM) protects large population of cells against non-Aβ component of Alzheimer's disease amyloid (NAC)-evoked cell death.
In Vivo

——
Synonyms

CAY10554
Pathway

Angiogenesis
Target

CDK
Recptor

Antifungal|Antiviral
Research Area

——
Indication

——

Chemical Information

CAS Number

267654-00-2
Formula Weight

260.36
Molecular Formula

C14H16N2OS
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 125 mg/mL (480.12 mM)
SMILES

O=C(NC1=NC=C(S1)C(C)C)CC=2C=CC=CC2
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.Freitas-Silva O, et al. Tracing fungi secondary metabolites in Brazil nuts using LC-MS/MS. Drug Metab Lett. 2011 Aug;5(3):150-5.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Bohemine

Bohemine is a cyclin-dependent kinase inhibitor.
CDK7 and 9 inhibitor...

A potent, selective transcriptional CDK inhibitor with Ki of 2.3 and 0.38 nM for CDK7 and CDK9, respectively; displays >30-fold selectivity over CDK1/2/4, inhibits VEGFR2 with IC50 of 180 nM in a panel of non-CDK kinases.
Tricin

Tricin can inhibit human cytomegalovirus (HCMV) replication by inhibiting CDK9.?Tricin inhibits the proliferation and invasion of C6 glioma cells via the upregulation of focal-adhesion-finase (FAK)-targeting microRNA-7.

Sign In Join Free